Syzygy specifications


Unique identifier OMICS_02166
Software type Package/Module
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux, Mac OS, Windows
Programming languages Python, R
License MIT License
Computer skills Advanced
Version 1.2.7
Stability Stable
Maintained Yes



Add your version



  • person_outline Mark Daly <>
  • person_outline Syzygy Team <>

Syzygy article

Syzygy citation

PMCID: 3772057

[…] v.3.1 software, and genotyping oligonucleotides were synthesized at integrated dna technologies. the correlation coefficient between observed minor allele frequencies and frequencies estimated from syzygy for validated variants was calculated in order to evaluate the overall quality of our dataset (figure s2). eighty-four high quality non-synonymous coding variants (missense, nonsense […]

Syzygy institution(s)
Analytic and Translational Genetics Unit (ATGU), Massachusetts General Hospital, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Universite de Montréal and Research Centre, Montreal Heart Institute, Montreal, Quebec, Canada
Syzygy funding source(s)
Supported by NHGRI Sequencing Grant, and DK 83756, Funds from the Helmsley Trust, National Institutes of Health Grants AI062773, DK060049 and DK043351, fellowships from La Fondation pour la Recherche Medicale and the Crohn’s and Colitis Foundation of America, grants from the U.S. National Institutes of Allergy and Infectious Diseases (AI065687; AI067152) from the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (DK064869; DK062432), the Crohn’s and Colitis Foundation of America (SRA512), la Fondation de l’institut de cardiologie de Montréal, the Crohn’s and Colitis Foundation of Canada (CCFC), the Fonds de Recherche en Santé du Québec, and the Canadian Institutes of Health Research, the Italian Ministry for Health GR-2008-1144485 and unrestricted research grant of Giuliani spa, with case collections provided by the Italian Group for IBD (IG-IBD), grants: DK062431, DK062422, DK062420, DK062432, DK062423, DK062413, and DK062429, NCRR grant M01-RR00425 to the Cedars-Sinai General Research Center Genotyping core U01-DK062413(IBD GRC), P01-DK046763 (IBD PPG), Southern California Diabetes Endocrinology Research Center grant, DK063491, R21-DK84554-01, and U01 DK062413, the German Ministry of Education and Research through the National Genome Research Network (NGFN), the Swedish Research Council, the Bengt Ihre’s Foundation, and the Örebro University Hospital Research foundation.

Syzygy reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Syzygy

Related Tools